BCM
DGX icon

Becker Capital Management’s Quest Diagnostics DGX Stock Holding History

Becker Capital Management’s Portfolio DGX Stock Details DGX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$12.9M Sell
60,916
-1,933
-3% -$379K 0.35% 75
2026
Q1 		$12.3M Buy
62,849
+683
+1% +$133K 0.36% 75
2025
Q4 		$10.8M Sell
62,166
-1,951
-3% -$355K 0.31% 78
2025
Q3 		$12.2M Sell
64,117
-1,135
-2% -$201K 0.36% 70
2025
Q2 		$11.7M Sell
65,252
-954
-1% -$166K 0.37% 74
2025
Q1 		$11.2M Sell
66,206
-7,483
-10% -$1.23M 0.37% 78
2024
Q4 		$11.1M Sell
73,689
-12,039
-14% -$1.87M 0.36% 73
2024
Q3 		$13.3M Sell
85,728
-739
-0.9% -$110K 0.43% 68
2024
Q2 		$11.8M Sell
86,467
-7,362
-8% -$1.01M 0.41% 74
2024
Q1 		$12.5M Sell
93,829
-31,275
-25% -$4.06M 0.43% 72
2023
Q4 		$17.2M Sell
125,104
-1,248
-1% -$164K 0.62% 58
2023
Q3 		$15.4M Buy
126,352
+16
+0% +$2.13K 0.61% 61
2023
Q2 		$17.8M Sell
126,336
-6,076
-5% -$838K 0.67% 59
2023
Q1 		$18.7M Sell
132,412
-1,544
-1% -$221K 0.74% 55
2022
Q4 		$21M Sell
133,956
-3,762
-3% -$541K 0.98% 41
2022
Q3 		$16.9M Sell
137,718
-4,805
-3% -$633K 0.89% 46
2022
Q2 		$19M Buy
142,523
+9,494
+7% +$1.29M 0.91% 45
2022
Q1 		$18.2M Buy
133,029
+15,085
+13% +$2.1M 0.73% 56
2021
Q4 		$20.4M Sell
117,944
-3,710
-3% -$564K 0.81% 53
2021
Q3 		$17.7M Buy
121,654
+7,737
+7% +$1.13M 0.74% 57
2021
Q2 		$15M Sell
113,917
-546
-0.5% -$71.5K 0.64% 60
2021
Q1 		$14.7M Buy
114,463
+879
+0.8% +$108K 0.66% 57
2020
Q4 		$13.5M Sell
113,584
-9,670
-8% -$1.18M 0.67% 57
2020
Q3 		$14.1M Sell
123,254
-2,980
-2% -$352K 0.78% 51
2020
Q2 		$14.4M Sell
126,234
-13,834
-10% -$1.47M 0.81% 56
2020
Q1 		$11.2M Sell
140,068
-58,547
-29% -$6.06M 0.68% 56
2019
Q4 		$21.2M Buy
+198,615
New +$20.7M 0.75% 57
2017
Q2 		– Sell
-6,300
Closed -$619K – 137
2017
Q1 		$619K Hold
6,300
– – 0.02% 96
2016
Q4 		$579K Hold
6,300
– – 0.02% 102
2016
Q3 		$533K Buy
+6,300
New +$529K 0.02% 102

Other funds holding DGX

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Boston Partners
Boston Partners Boston, Massachusetts $113B AUM 38.87% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
EIG
EdgePoint Investment Group Toronto, Ontario, Canada $13.2B AUM 32.43% 1-Year Est. Return

Becker Capital Management's DGX Position: Q2 2026 in Review

Becker Capital Management reduced its Quest Diagnostics (DGX) stake by 3.1% in Q2 2026, selling an estimated $379K and leaving 60,916 shares worth $12.9M. The position accounts for 0.35% of the portfolio, ranked #75.

Becker Capital Management first reported a position in DGX in Q3 2016 and has held it in 30 quarters since. The position peaked at $21.2M in Q4 2019. 1,106 funds tracked by Wall St. Rank hold DGX as of Q2 2026.

  • Becker Capital Management held 60,916 shares of Quest Diagnostics worth $12.9M as of Q2 2026.
  • Becker Capital Management sold 1,933 Quest Diagnostics shares in Q2 2026, an estimated $379K.
  • Quest Diagnostics made up 0.35% of Becker Capital Management's portfolio in Q2 2026, its #75 holding.
  • Becker Capital Management first reported a position in Quest Diagnostics in Q3 2016 and has held it in 30 quarters since.
  • Becker Capital Management's Quest Diagnostics position peaked at $21.2M in Q4 2019.
  • 1,106 funds tracked by Wall St. Rank held Quest Diagnostics as of Q2 2026.

Based on Becker Capital Management's 13F filing for Q2 2026, filed 31 Jul 2026.